The story of Viagra and its influence on the healthcare landscape presents a thorny question for shareholders . Initially a massive drug, generics have significantly chipped away at its market dominance, https://marcaqyt763323.ka-blogs.com/95215151/the-blue-pill-and-pharma-a-risky-investment